Vicky Kuo is a pharmacist who is specialized in Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist in San Francisco, California. Patients can reach her at University Of California San Francisco, 533 Parnassus Ave, Room U-585, San Francisco or contact her on 415-353-1335. Active license number of Vicky Kuo is 73361 for Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist in California. Vicky Kuo is pharmacist Clinician/Clinical Pharmacy Specialist is a pharmacist with additional training and an expanded scope of practice that may include prescriptive authority, therapeutic management, and disease management.
Complete Profile:
Vicky Kuo speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
University Of California San Francisco, 533 Parnassus Ave, Room U-585, San Francisco, California, 94143-2208
Phone:
415-353-1335
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Vicky Kuo are as mentioned below.
NPI Number:
1962916858
NPI Enumeration Date:
30 Nov, 2017
NPI Last Update On:
30 Nov, 2017
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Vicky Kuo are as mentioned below.
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
40 Arroyo View Cir, Belmont, California
Zip:
94002-3184
Phone Number:
909-525-8519
Fax Number:
--
Patients can reach Vicky Kuo at University Of California San Francisco, 533 Parnassus Ave, Room U-585, San Francisco, California or can call on phone at 415-353-1335.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.